Prolonged APTT

1

Review clinical trials related to Prolonged APTT. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis

Prolonged activated partial thromboplastin time (APTT) is a frequent laboratory finding that may reflect a broad spectrum of underlying conditions, ranging from benign laboratory abnormalities to clinically relevant hemostatic disorders. Clot waveform analysis (CWA), automatically generated during routine APTT testing by optical coagulation analyzers, provides additional quantitative and qualitative information on clot formation dynamics. The APTTO model is a previously developed two-step predictive algorithm based on CWA features designed to estimate the probability of a pathological cause of prolonged APTT and to differentiate lupus anticoagulant from intrinsic pathway factor deficiency or von Willebrand disease. Internal validation has demonstrated good discrimination and calibration. This multicenter observational study aims to perform an external validation of the APTTO model in independent patient cohorts, assessing its discrimination, calibration, and decision-analytic performance without model updating.

Participants needed: 1,500
Trial details
Biological sex: AllType: ObservationalSponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez DíazUpdated: May 1, 2026Locations: 16
Eligibility criteria

Optical coagulation analyzers (ACL TOP platform). [+5]

Prolonged prothrombin time (PT) or combined prolongation of PT and APTT. [+3]